Chronic myeloid leukemia: advances in understanding disease biology and mechanisms of resistance to tyrosine kinase inhibitors.
about
Multifunctional Abl kinases in health and diseaseTargeting the TAM Receptors in LeukemiaBosutinib as a fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia: A case report.Differentiation status of primary chronic myeloid leukemia cells affects sensitivity to BCR-ABL1 inhibitors.CEBPA-mediated upregulation of the lncRNA PLIN2 promotes the development of chronic myelogenous leukemia via the GSK3 and Wnt/β-catenin signaling pathways.The Emerging Role of ABL Kinases in Solid Tumors.An activating mutation of GNB1 is associated with resistance to tyrosine kinase inhibitors in ETV6-ABL1-positive leukemia.The effect of the additional cytogenetic abnormalities on major molecular response and BCR-ABL kinase domain mutations in long-term follow-up chronic myeloid leukemia patients, a cross sectional study.Mechanisms of Resistance to ABL Kinase Inhibition in Chronic Myeloid Leukemia and the Development of Next Generation ABL Kinase Inhibitors.Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.Induction of apoptosis in imatinib sensitive and resistant chronic myeloid leukemia cells by efficient disruption of bcr-abl oncogene with zinc finger nucleases.Deregulation of calcium homeostasis in Bcr-Abl-dependent chronic myeloid leukemia.
P2860
Q26771277-4CE22599-0B6E-4F1C-9F4A-CA3124D70ED9Q28078654-DDCCA6C9-B23D-4985-A2CE-37BEEE697B26Q33442587-EB8CE6F7-2C16-417F-9833-EE1E49987F5EQ33618407-193267D0-D11A-4844-9F32-585B6D11CC33Q33732992-ADB99D18-39F8-4395-84AE-073193834F4DQ36347666-33C236D1-BA3B-4591-B3D8-94B1092313ACQ38699035-66A8B63D-B023-45E2-91E8-5F55582A9591Q39125138-38F6F0C7-71E6-4C7C-B744-838EC590716EQ39411920-43FA4B06-729B-4D24-8F30-DB35B1815B97Q41279430-EB9C307B-0C94-40FF-B76F-D5548AC11539Q52648378-E83215EF-857D-46E4-A256-2A82A47573AEQ55025859-682350D3-8BFB-4BFF-B789-8760847BDF19
P2860
Chronic myeloid leukemia: advances in understanding disease biology and mechanisms of resistance to tyrosine kinase inhibitors.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Chronic myeloid leukemia: adva ...... to tyrosine kinase inhibitors.
@en
type
label
Chronic myeloid leukemia: adva ...... to tyrosine kinase inhibitors.
@en
prefLabel
Chronic myeloid leukemia: adva ...... to tyrosine kinase inhibitors.
@en
P2860
P1476
Chronic myeloid leukemia: adva ...... to tyrosine kinase inhibitors.
@en
P2093
Christopher A Eide
Thomas O'Hare
P2860
P2888
P304
P356
10.1007/S11899-015-0248-3
P577
2015-06-01T00:00:00Z
P6179
1022691728